GlassScriptPhysician profile
Matthew E Stotz
NPI 1063738235
$8,277.86
in general payments reported to CMS, 2019-2025
49 companies · $846 in 2025
The $846 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $973 · 2020: $993 · 2021: $1,183 · 2022: $1,773 · 2023: $1,697 · 2024: $813 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,799 · Travel and Lodging: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,799.20 |
| Travel and Lodging | $557.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $668.04 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Teva Pharmaceuticals USA, INC. | $606.62 | 2020-2024 | Austedo Xr, Austedo, Ajovy |
| Medtronic, INC. | $557.02 | 2023 | |
| Amgen INC. | $517.36 | 2019-2023 | Aimovig |
| Biogen, INC. | $514.35 | 2019-2025 | Leqembi |
| Lilly USA, LLC | $493.56 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Argenx US, INC. | $375.92 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Mdd US Operations, LLC | $365.92 | 2019-2024 | Gocovri, Gocovri |
| Novartis Pharmaceuticals Corporation | $361.18 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $334.47 | 2019-2025 | Ultomiris |
| Kyowa Kirin, INC. | $317.88 | 2019-2024 | Nourianz |
| Neurocrine Biosciences, INC. | $305.26 | 2021-2025 | Ongentys |
| Sk Life Science, INC. | $266.48 | 2020-2025 | |
| Pfizer INC. | $263.22 | 2023-2025 | |
| Neuronetics, INC. | $225.26 | 2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Stotz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.